Flotek Announces Increased 2024 Guidance and Continued Profitability Growth in Connection with Second Quarter 2024 Results

HOUSTON, Aug. 6, 2024 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK) today announced operational and financial results for the quarter ended June 30, 2024, highlighted by significant improvement in profitability metrics as compared to the second quarter of 2023. Due to the strong business performance in the first half of the year, the Company increased its 2024 profitability guidance.

Financial Summary (in thousands, except 'per share' amounts)


                                              Three Months Ended June 30,            Six Months Ended June 30,


                                         2024             2023               2024      2023





     Total Revenues                  $46,152          $50,594            $86,526   $98,602



     Gross Profit                     $9,170           $3,904            $17,991    $5,785



     Adjusted Gross Profit (1)       $10,654           $5,092            $20,729    $7,740



     Net Income (Loss)                $1,974            $(21)            $3,536   $21,322



     Diluted Income (Loss) Per Share   $0.06          $(0.11)             $0.12   $(0.23)



     Adjusted EBITDA (1)              $4,439         $(2,003)            $8,464  $(5,854)

Second Quarter 2024 and Recent Highlights

    --  Generated total revenue of $46.2 million, a 14% increase from the first
        quarter of 2024, driven by a 40% sequential increase in chemistry
        revenues from external customers and a 22% sequential increase in Data
        Analytics revenue.
    --  Increased gross profit margin and adjusted gross profit margin((1)) to
        20% and 23%, respectively, as compared to 8% and 10% respectively,
        during the second quarter 2023.
    --  Reported net income of $2.0 million compared to a net loss of $21
        thousand for the second quarter of 2023 and delivered a year-over-year
        increase in adjusted EBITDA((1) )of $6.4 million.
    --  Amended Asset Based Loan agreement increases loan commitment by 45% to
        $20 million and reduces interest rate.
    --  Received approval from the Environmental Protection Agency (EPA) of the
        JP3 analyzer system for use in flare emission monitoring, facilitating
        access to a new upstream market application with an estimated annual
        total addressable market of $220 million.

2024 Guidance: Stronger Profitability Expectations

As a result of the Company's strong operational performance during the first half of 2024 and the outlook for the balance of the year, the Company is raising its 2024 profitability guidance. Flotek now expects adjusted EBITDA((2)) to be in a range of between $14 million and $18 million, a 23% increase to the midpoint of the range when compared to the prior guidance range of between $10 million and $16 million.

Asset Based Loan Amendment: Increased Credit Capacity with Lower Interest Rate

On August 5, 2024, the Company entered into an amendment to its Asset Based Loan agreement. In connection with the amendment, the loan commitment increased by 45% from $13.8 million to $20 million, the applicable interest rate spread decreased by 0.50% and the term of the loan was extended by one year to August 2026. These enhancements to the loan agreement further validate the Company's continuing operational and financial improvements.

Data Analytics: Access to New Upstream Flare Market

On July 16, 2024, Flotek announced that the EPA designated the JP3 system as an approved measurement technology with respect to recently enacted flare regulations. This state-of-the-art optical instrument, designed for the precise measurement of net heating values (NHV) in flare gases, is the first to be approved as an alternative method under the new NSPS OOOOb regulations, supporting cleaner and more efficient operations across the oil and gas industry.

With over 55,000 existing flares in the United States expected to be subject to some level of monitoring regulation by 2028, this approval is expected to position JP3 to significantly expand its footprint into this new upstream market space.

Management Commentary

Chief Executive Officer Dr. Ryan Ezell commented, "Despite a backdrop of slower North American activity in our industry, our ability to grow revenue 14% this quarter speaks to the execution of our strategy and the continued progress we are making in gaining market share. Second quarter revenue from external customers increased significantly following the seasonality we experienced in the first quarter. Our Data Analytics segment increased revenue 22% from the first quarter 2024 as we saw a sequential improvement in analyzer sales. Most importantly, we received notification from the EPA that our JP3 analyzer was an approved technology for flare gas monitoring, which we believe will be a catalyst for revenue growth later this year and into 2025.

Based on our performance through mid-year, I am excited to share that we are raising the mid-point of our adjusted EBITDA((2)) guidance for 2024 to $16 million, which would represent more than a 900% improvement from 2023. This is a testament to Flotek's differentiated technology solutions in a competitive market as the industry navigates through this current natural gas price environment. Lastly, our success in significantly increasing our ABL credit capacity at a lower interest rate will provide incremental liquidity to support our continued growth."

Second Quarter 2024 Financial Results

    --  Revenue: Flotek reported total revenues of $46.2 million for the second
        quarter of 2024, which was an increase of $5.8 million, or 14% compared
        to total revenues in the first quarter of 2024. Quarterly revenue growth
        was driven by a 40% sequential increase in chemistry revenue from
        external customers, highlighting the Company's continued market share
        improvement when considering the decline of 23 active frac fleets from
        the end of the first quarter of 2024((3)). Revenue from the Data
        Analytics segment totaled $2 million during the second quarter of 2024,
        as compared to $1.7 million during the first quarter of 2024. Total
        revenues for the second quarter of 2024 were down $4.4 million, or 9%,
        compared to total revenues of $50.6 million for the second quarter 2023.
        The decline in total revenue compared to the second quarter of 2023 was
        primarily due to reduced related party activity as a result of lower
        natural gas prices. Chemistry revenues from external customers during
        the second quarter 2024 were 6% higher than the second quarter 2023.

    --  Gross Profit: The Company generated gross profit of $9.2 million during
        the second quarter 2024 as compared to gross profit of $3.9 million for
        the second quarter 2023. The improvement was the result of increased
        revenue attributable to the estimated annual minimum chemistry purchase
        requirement in the ProFrac supply agreement. The measurement period
        during 2023 for minimum chemistry purchase requirements was June 1
        through December 31, 2023 compared to January 1 through December 31,
        2024 during 2024.

    --  Adjusted Gross Profit (Non-GAAP)((1)): Flotek generated adjusted gross
        profit of $10.7 million during the second quarter 2024 compared to
        adjusted gross profit of $5.1 million for the second quarter 2023.
        Adjusted gross profit excludes non-cash items, primarily amortization of
        contract assets.

    --  Selling, General and Administrative ("SG&A") Expense: SG&A expense
        totaled $6.3 million for the second quarter 2024 compared to $8.4
        million for the second quarter 2023. The improvement was the result of
        lower personnel costs and professional fees during the 2024 period.

    --  Severance Costs: Flotek recorded a $2.3 million credit to severance
        costs in the second quarter of 2023 in connection with the settlement of
        certain litigation.

    --  Net Income and EPS: Flotek reported net income of $2.0 million, or $0.06
        per diluted share, for the second quarter 2024. This compares to a net
        loss of $21 thousand, or $(0.11) per diluted share, for the second
        quarter 2023.
    --  Adjusted EBITDA (Non-GAAP)((1)): Adjusted EBITDA was $4.4 million in the
        second quarter 2024 as compared to negative $2.0 million in the second
        quarter 2023. Adjusted EBITDA improved by 10% from the first quarter of
        2024, marking seven consecutive quarters of improvement.


     (1)   A non-GAAP financial measure. See the "Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings" section in this release for more information, including reconciliations to the most comparable GAAP measures.



     (2)   A non-GAAP financial measure. See the "Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings" section in this release for more information, including reconciliations to the most comparable GAAP measures. We
              are unable to reconcile this forward-looking non-GAAP financial measure to the most directly comparable GAAP financial measure without unreasonable efforts, as we are unable to predict with a reasonable degree of certainty the impact
              of certain items that would be expected to impact the GAAP financial measure, including, among other items, the future amortization of our contract assets, certain stock-based compensation costs and the impact of the revaluation of
              certain liabilities, which is based upon our future stock price. These items do not impact the non-GAAP financial measure.



     (3) 
     As reported by The American Oil and Gas Reporter weekly Frac Spread Counts on March 29, 2024 and June 28, 2024.

Conference Call Details

Flotek will host a conference call on August 7, 2024, at 9:00 a.m. CT (10:00 a.m. ET) to discuss its second quarter 2024 results. Participants may access the call through Flotek's website at www.flotekind.com under "News" within the Investor Relations section or by telephone toll free at 1-800-836-8184 (international toll: 1-646-357-8785) or use the following link to access the audience view of the webcast at https://app.webinar.net/zpvrjZ72oQw approximately five minutes prior to the start of the call. Following the conclusion of the conference call, a recording of the call will be available on the Company's website.

An updated corporate presentation that will be referenced on the call will be posted to the Investor Relations section of Flotek's website at www.flotekind.com prior to the start of the earnings conference call.

Upcoming Investor Event

Members of the Company's management are scheduled to participate in EnerCom Denver - The Energy Investment Conference to be held in Denver, Colorado, August 18-21, 2024. Ryan Ezell, Chief Executive Officer of Flotek, will present on August 19, 2024, at 9:15 a.m. MT and will be joined by Bond Clement, Chief Financial Officer, in hosting meetings with investors throughout the conference. A live webcast of the presentation will be available on the conference website at www.enercomdenver.com. Presentation slides will be posted on the Investor Relations section of Flotek's corporate website at www.flotekind.com prior to the start of the presentation.

About Flotek Industries, Inc.

Flotek Industries, Inc. is an advanced technology-driven, green chemical and data analytics company providing unique and innovative completion solutions that have a proven, positive impact on sustainability and reducing the overall environmental impact of energy on air, land, water and people. Flotek has an intellectual property portfolio of over 170 patents and a global presence in more than 59 countries throughout North America, Latin America, the Middle East and North Africa. Flotek has established collaborative partnerships focused on sustainable and optimized chemistry and data solutions which improve well performance and allow its customers to generate higher returns on invested capital.

Flotek is based in Houston, Texas and its common shares are traded on the New York Stock Exchange under the ticker symbol "FTK". For additional information, please visit www.flotekind.com.

Forward-Looking Statements

Certain statements set forth in this press release constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.'s business, financial condition, results of operations and prospects. Words such as will, continue, expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this press release. Although forward-looking statements in this press release reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Further information about the risks and uncertainties that may impact the Company are set forth in the Company's most recent filing with the Securities and Exchange Commission on Form 10-K (including, without limitation, in the "Risk Factors" section thereof), and in the Company's other SEC filings and publicly available documents. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this press release.


                                                                                  
              
                FLOTEK INDUSTRIES, INC.

                                                                      
              
                 UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

                                                                             
              
                (in thousands, except share data)




                                                                                                                                               June 30, 2024 December 31, 2023


                                                                                         
              
                ASSETS



              Current assets:



              Cash and cash equivalents                                                                                                              $4,777             $5,851



              Restricted cash                                                                                                                           101                102



              Accounts receivable, net of allowance for credit losses of $410 and $745 at                                                            13,316             13,687
    June 30, 2024 and December 31, 2023, respectively



              Accounts receivable, related party, net of allowance for credit losses of $0 at                                                        40,049             34,569
    each June 30, 2024 and December 31, 2023, respectively



              Inventories, net                                                                                                                       12,142             12,838



              Other current assets                                                                                                                    2,834              3,564



              Current contract asset                                                                                                                  5,786              5,836



              Total current assets                                                                                                                   79,005             76,447



              Long-term contract assets                                                                                                              66,121             68,820



              Property and equipment, net                                                                                                             4,987              5,129



              Operating lease right-of-use assets                                                                                                     4,184              5,030



              Deferred tax assets, net                                                                                                                   84                300



              Other long-term assets                                                                                                                  1,659              1,787



              
                TOTAL ASSETS                                                                                                            $156,040           $157,513




                                                                          
              
                LIABILITIES AND STOCKHOLDERS' EQUITY



              Current liabilities:



              Accounts payable                                                                                                                      $31,755            $31,705



              Accrued liabilities                                                                                                                     3,026              5,890



              Income taxes payable                                                                                                                       35                 45



              Current portion of operating lease liabilities                                                                                          1,866              2,449



              Current portion of finance lease liabilities                                                                                                3                 22



              Asset-based loan                                                                                                                        5,798              7,492



              Current portion of long-term debt                                                                                                         149                179



              Total current liabilities                                                                                                              42,632             47,782



              Deferred revenue, long-term                                                                                                                35                 35



              Long-term operating lease liabilities                                                                                                   7,139              7,676



              Long-term debt                                                                                                                              -                60



              
                TOTAL LIABILITIES                                                                                                         49,806             55,553



              Commitments and contingencies



              Stockholders' equity:



              Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares                                                                    -
         issued and outstanding



              Common stock, $0.0001 par value, 240,000,000 shares authorized;                                                                             3                  3
         30,866,597 shares issued and 29,759,154 shares outstanding at June 30,
         2024; 30,772,837 shares issued and 29,664,130 shares outstanding at
         December 31, 2023



              Additional paid-in capital                                                                                                            463,844            463,140



              Accumulated other comprehensive income                                                                                                    185                127



              Accumulated deficit                                                                                                                 (323,270)         (326,806)



              Treasury stock, at cost; 1,107,442 and 1,108,707 shares at June 30, 2024                                                             (34,528)          (34,504)
         and December 31, 2023, respectively



              Total stockholders' equity                                                                                                            106,234            101,960



              
                TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                                                                              $156,040           $157,513


                                                                 
           
                FLOTEK INDUSTRIES, INC.

                                                    
              
         Unaudited Condensed Consolidated Statements of Operations

                                                              
        
               (in thousands, except per share data)




                                                                                                                                Three Months Ended June 30,              Six Months Ended June 30,


                                                                                                                     2024                                   2023    2024              2023



              
                Revenue:



              Revenue from external customers                                                                    $18,191                                $17,820 $31,371           $29,472



              Revenue from related party                                                                          27,961                                 32,774  55,155            69,130



              
                Total revenues                                                                         46,152                                 50,594  86,526            98,602



              
                Cost of goods sold                                                                     36,982                                 46,690  68,535            92,817



              
                Gross profit                                                                            9,170                                  3,904  17,991             5,785



              
                Operating costs and expenses:



              Selling, general, and administrative                                                                 6,259                                  8,351  12,342            14,803



              Depreciation                                                                                           222                                    174     442               349



              Research and development                                                                               481                                    860     888             1,474



              Severance costs                                                                                         20                                (2,279)     23              (56)



              Gain on sale of property and equipment                                                                (34)                                         (34)



              Gain in fair value of Contract Consideration                                                             -                               (3,874)                (29,969)
    Convertible Notes Payable



              Total operating costs and expenses                                                                   6,948                                  3,232  13,661          (13,399)



              
                Income from operations                                                                  2,222                                    672   4,330            19,184



              
                Other income (expense):



              Paycheck protection plan loan forgiveness                                                                -                                                         4,522



              Interest expense                                                                                     (308)                                 (705)  (586)          (2,377)



              Other income, net                                                                                       75                                     19      49                 9



              Total other income (expense)                                                                         (233)                                 (686)  (537)            2,154



              
                Income (loss) before income taxes                                                       1,989                                   (14)  3,793            21,338



              Income tax expense                                                                                    (15)                                   (7)  (257)             (16)



              
                Net income (loss)                                                                      $1,974                                  $(21) $3,536           $21,322





              
                Income (loss) per common share:



              Basic                                                                                                $0.07      
              $                    -  $0.12             $1.06



              Diluted                                                                                              $0.06                                $(0.11)  $0.12           $(0.23)





              
                Weighted average common shares:



              Weighted average common shares used in                                                              29,449                                 23,906  29,440            20,207
         computing basic income (loss) per common
         share



              Weighted average common shares used in                                                              30,668                                 28,250  30,512            27,361
         computing diluted income (loss) per common
         share


                                                                                
              
                FLOTEK INDUSTRIES, INC.

                                                               
              
                UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

                                                                                    
              
                (in thousands)




                                                                                                                                                         Six Months Ended June 30,


                                                                                                                                                    2024               2023



     
                Cash flows from operating activities:



     Net income                                                                                                                                  $3,536            $21,322



     Adjustments to reconcile net income to net cash provided by (used in) operating activities:



     Change in fair value of contingent consideration                                                                                              (27)             (324)



     Change in fair value of Contract Consideration Convertible Notes Payable                                                                         -          (29,969)



     Amortization of convertible note issuance costs                                                                                                  -                83



     Payment-in-kind interest expense                                                                                                                 -             2,284



     Amortization of contract assets                                                                                                              2,749              2,390



     Depreciation                                                                                                                                   442                349



     Amortization of asset-based loan origination costs                                                                                             170



     Provision for credit losses, net of recoveries                                                                                                  79                 63



     Provision for excess and obsolete inventory                                                                                                    433                497



     Gain on sale of property and equipment                                                                                                        (34)



     Non-cash lease expense                                                                                                                       1,236              1,621



     Stock compensation expense                                                                                                                     642              (836)



     Deferred income tax expense                                                                                                                    216



     Paycheck protection plan loan forgiveness                                                                                                        -           (4,522)



     Changes in current assets and liabilities:



     Accounts receivable                                                                                                                            292              2,218



     Accounts receivable, related party                                                                                                         (5,480)             (350)



     Inventories                                                                                                                                    192            (3,158)



     Other assets                                                                                                                                   688                (6)



     Accounts payable                                                                                                                                50             11,574



     Accrued liabilities                                                                                                                        (2,837)           (3,491)



     Operating lease liabilities                                                                                                                (1,510)           (1,886)



     Income taxes payable                                                                                                                          (10)              (85)



     Interest payable                                                                                                                                 -               (8)



     Net cash provided by (used in) operating activities                                                                                            827            (2,234)


                                                           
              
                FLOTEK INDUSTRIES, INC.

                                          
              
                UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

                                                               
              
                (in thousands)

                                                                 
              
                (continued)




                                                                                                                                     Six Months Ended June 30,


                                                                                                                                2024               2023



     
                Cash flows from investing activities:



     Capital expenditures                                                                                                     (229)             (292)



     Proceeds from sale of assets                                                                                                34



     Net cash used in investing activities                                                                                    (195)             (292)



     
                Cash flows from financing activities:



     Payment for forfeited stock options                                                                                          -             (617)



     Payments on long term debt                                                                                                (90)              (60)



     Proceeds from asset-based loan                                                                                          83,300



     Payments on asset-based loan                                                                                          (84,994)



     Payments to tax authorities for shares withheld from employees                                                            (24)             (229)



     Proceeds from issuance of stock                                                                                             62                 33



     Payments for finance leases                                                                                               (19)              (15)



     Net cash used in financing activities                                                                                  (1,765)             (888)



     
                Effect of changes in exchange rates on cash and cash equivalents                                               58               (34)



     
                Net change in cash and cash equivalents and restricted cash                                               (1,075)           (3,448)



     Cash and cash equivalents at the beginning of period                                                                     5,851             12,290



     Restricted cash at the beginning of period                                                                                 102                100



     
                Cash and cash equivalents and restricted cash at beginning of period                                        5,953             12,390



     Cash and cash equivalents at end of period                                                                               4,777              8,841



     Restricted cash at the end of period                                                                                       101                101



     
                Cash and cash equivalents and restricted cash at end of period                                             $4,878             $8,942


                                                       
              
                FLOTEK INDUSTRIES, INC.

                           
              
                Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings

                                                            
              
                (in thousands)




                                                                                                                         Three Months Ended June 30,                     Six Months Ended June 30,


                                                                                                           2024                   2023                  2024        2023





              
                Gross profit                                                                 $9,170                 $3,904               $17,991      $5,785



              Stock compensation expense                                                                     3                      2                     7       (137)



              Severance and retirement                                                                       -                    11                     9          26



              Contingent liability revaluation                                                             (1)                    35                  (27)      (324)



              Amortization of contract assets                                                            1,482                  1,140                 2,749       2,390



              
                Adjusted Gross profit (Non-GAAP) (1)                                        $10,654                 $5,092               $20,729      $7,740





              
                Net income (loss)                                                            $1,974                  $(21)               $3,536     $21,322



              Interest expense                                                                             308                    705                   586       2,377



              Income tax expense                                                                            15                      7                   257          16



              Depreciation and amortization                                                                222                    173                   442         349



              
                EBITDA (Non-GAAP) (1)                                                        $2,519                   $864                $4,821     $24,064



              Stock compensation expense                                                                   331                    274                   643       (838)



              Severance and retirement                                                                      20                (2,268)                   32        (30)



              Contingent liability revaluation                                                               -                    35                  (27)      (324)



              Gain on disposal of assets                                                                  (34)                                       (34)



              PPP loan forgiveness                                                                           -                                               (4,522)



              Contract Consideration Convertible Notes                                                       -               (3,874)                        (29,969)
    Payable revaluation adjustment



              Amortization of contract assets                                                            1,482                  1,140                 2,749       2,390



              Non-Recurring professional fees                                                              121                  1,826                   280       3,375



              
                Adjusted EBITDA (Non-GAAP) (1)                                               $4,439               $(2,003)               $8,464    $(5,854)




     (1) Management believes that adjusted gross profit, EBITDA and adjusted EBITDA for the three and six months ended June 30, 2024 and 2023, are useful to investors to assess and understand operating performance, especially when comparing those
            results with previous and subsequent periods. Management views the income and expenses noted above to be outside of the Company's normal operating results. Management analyzes operating results without the impact of the above items as an
            indicator of performance, to identify underlying trends in the business and cash flow from continuing operations, and to establish financial and operational goals, excluding certain non-cash or non-recurring items.

View original content to download multimedia:https://www.prnewswire.com/news-releases/flotek-announces-increased-2024-guidance-and-continued-profitability-growth-in-connection-with-second-quarter-2024-results-302215804.html

SOURCE Flotek Industries, Inc.